552 related articles for article (PubMed ID: 12670925)
21. Cell density-dependent expression of EDG family receptors and mesangial cell proliferation: role in lysophosphatidic acid-mediated cell growth.
Xing Y; Ganji SH; Noh JW; Kamanna VS
Am J Physiol Renal Physiol; 2004 Dec; 287(6):F1250-7. PubMed ID: 15292052
[TBL] [Abstract][Full Text] [Related]
22. Lysophosphatidic acid (LPA) signaling via LPA
Takahashi K; Fukushima K; Onishi Y; Inui K; Node Y; Fukushima N; Honoki K; Tsujiuchi T
Biochem Biophys Res Commun; 2017 Jan; 483(1):652-657. PubMed ID: 27993681
[TBL] [Abstract][Full Text] [Related]
23. Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer.
Shida D; Watanabe T; Aoki J; Hama K; Kitayama J; Sonoda H; Kishi Y; Yamaguchi H; Sasaki S; Sako A; Konishi T; Arai H; Nagawa H
Lab Invest; 2004 Oct; 84(10):1352-62. PubMed ID: 15220934
[TBL] [Abstract][Full Text] [Related]
24. Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1.
Yamada T; Sato K; Komachi M; Malchinkhuu E; Tobo M; Kimura T; Kuwabara A; Yanagita Y; Ikeya T; Tanahashi Y; Ogawa T; Ohwada S; Morishita Y; Ohta H; Im DS; Tamoto K; Tomura H; Okajima F
J Biol Chem; 2004 Feb; 279(8):6595-605. PubMed ID: 14660630
[TBL] [Abstract][Full Text] [Related]
25. Lysophosphatidic acid stimulates activation of focal adhesion kinase and paxillin and promotes cell motility, via LPA1-3, in human pancreatic cancer.
Liao Y; Mu G; Zhang L; Zhou W; Zhang J; Yu H
Dig Dis Sci; 2013 Dec; 58(12):3524-33. PubMed ID: 24061591
[TBL] [Abstract][Full Text] [Related]
26. Specific LPA receptor subtype mediation of LPA-induced hypertrophy of cardiac myocytes and involvement of Akt and NFkappaB signal pathways.
Chen J; Chen Y; Zhu W; Han Y; Han B; Xu R; Deng L; Cai Y; Cong X; Yang Y; Hu S; Chen X
J Cell Biochem; 2008 Apr; 103(6):1718-31. PubMed ID: 17891781
[TBL] [Abstract][Full Text] [Related]
27. LPA2 receptor mediates mitogenic signals in human colon cancer cells.
Yun CC; Sun H; Wang D; Rusovici R; Castleberry A; Hall RA; Shim H
Am J Physiol Cell Physiol; 2005 Jul; 289(1):C2-11. PubMed ID: 15728708
[TBL] [Abstract][Full Text] [Related]
28. Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion.
Shida D; Fang X; Kordula T; Takabe K; Lépine S; Alvarez SE; Milstien S; Spiegel S
Cancer Res; 2008 Aug; 68(16):6569-77. PubMed ID: 18701480
[TBL] [Abstract][Full Text] [Related]
29. Lysophosphatidic acid enhances human hepatocellular carcinoma cell migration, invasion and adhesion through P38 MAPK pathway.
Zhu B; Shi S; Ma YG; Fan F; Yao ZZ
Hepatogastroenterology; 2012 May; 59(115):785-9. PubMed ID: 22020916
[TBL] [Abstract][Full Text] [Related]
30. The LPA receptors.
Fukushima N; Chun J
Prostaglandins Other Lipid Mediat; 2001 Apr; 64(1-4):21-32. PubMed ID: 11324705
[TBL] [Abstract][Full Text] [Related]
31. Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer.
Fujita T; Miyamoto S; Onoyama I; Sonoda K; Mekada E; Nakano H
Cancer Lett; 2003 Mar; 192(2):161-9. PubMed ID: 12668280
[TBL] [Abstract][Full Text] [Related]
32. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax.
Goetzl EJ; Kong Y; Mei B
J Immunol; 1999 Feb; 162(4):2049-56. PubMed ID: 9973477
[TBL] [Abstract][Full Text] [Related]
33. Lysophosphatidic acid enhanced the angiogenic capability of human chondrocytes by regulating Gi/NF-kB-dependent angiogenic factor expression.
Chuang YW; Chang WM; Chen KH; Hong CZ; Chang PJ; Hsu HC
PLoS One; 2014; 9(5):e95180. PubMed ID: 24879414
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mobility assay device.
Yamauchi A; Yamamura M; Katase N; Itadani M; Okada N; Kobiki K; Nakamura M; Yamaguchi Y; Kuribayashi F
BMC Cancer; 2017 Mar; 17(1):234. PubMed ID: 28359316
[TBL] [Abstract][Full Text] [Related]
35. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer.
Goetzl EJ; Dolezalova H; Kong Y; Hu YL; Jaffe RB; Kalli KR; Conover CA
Cancer Res; 1999 Oct; 59(20):5370-5. PubMed ID: 10537322
[TBL] [Abstract][Full Text] [Related]
36. Antidepressants activate the lysophosphatidic acid receptor LPA(1) to induce insulin-like growth factor-I receptor transactivation, stimulation of ERK1/2 signaling and cell proliferation in CHO-K1 fibroblasts.
Olianas MC; Dedoni S; Onali P
Biochem Pharmacol; 2015 Jun; 95(4):311-23. PubMed ID: 25888927
[TBL] [Abstract][Full Text] [Related]
37. Altered expression and functional profile of lysophosphatidic acid receptors in mitogen-activated human blood T lymphocytes.
Zheng Y; Voice JK; Kong Y; Goetzl EJ
FASEB J; 2000 Dec; 14(15):2387-9. PubMed ID: 11024010
[TBL] [Abstract][Full Text] [Related]
38. Lysophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA(1/3), COX-2, and NF-kappaB activation- and EGFR transactivation-dependent mechanisms.
Lin CI; Chen CN; Huang MT; Lee SJ; Lin CH; Chang CC; Lee H
Cell Signal; 2008 Oct; 20(10):1804-14. PubMed ID: 18627789
[TBL] [Abstract][Full Text] [Related]
39. Lysophosphatidic acid inhibits Ca2+ signaling in response to epidermal growth factor receptor stimulation in human astrocytoma cells by a mechanism involving phospholipase C(gamma) and a G(alphai) protein.
Hernández M; Barrero MJ; Crespo MS; Nieto ML
J Neurochem; 2000 Oct; 75(4):1575-82. PubMed ID: 10987838
[TBL] [Abstract][Full Text] [Related]
40. LPA-induced migration of ovarian cancer cells requires activation of ERM proteins via LPA
Park J; Jang JH; Oh S; Kim M; Shin C; Jeong M; Heo K; Park JB; Kim SR; Oh YS
Cell Signal; 2018 Apr; 44():138-147. PubMed ID: 29329782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
